Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy

Contributions to Nephrology

Volumn 157, Issue , 2007, Pages 114-119

  Ishii, Takeo ^a   Kawamura, Tetsuya ^a   Tsuboi, Nobuo ^a   Ogura, Makoto ^a   Utsunomiya, Yasunori ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; WARFARIN;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, IGA; HEPARIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; TREATMENT OUTCOME; WARFARIN;

EID: 34249023654     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102314     Document Type: Conference Paper

References (18)

1. Praga M, Gutierrez E, Gonzalez E, et al: Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J Am Soc Nephrol 2003;14:1578-1583.
2. Ogura M, Ito Y, Utsunomiya Y, Kawamura T, et al: Combined therapy with steroid, ACE inhibitor and anticoagulant improved the long-term prognosis of advanced IgA nephropathy. J Am Soc Nephrol 2004;15:332A.
3. Sarasin FP, Schifferli JA: Prophylactic oral anticoagulation in nephritic patients with idiopathic membranous nephropathy. Kidney Int 1994;45:578-585.
4. Castellot JJ, Hoover RL, Harper PA, et al: Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. Am J Pathol 1985;120:427-435.
5. Floege J, Eng E, Young BA, et al: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993;43:369-380.
6. Burg M, Ostendorf T, Mooney A, et al: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety. Lab Invest 1997;76: 505-516.
7. Caenazzo C, Garbisa S, Onisto M, et al: Effect of glucose and heparin on mesangial (IV) COLL and MMP-2/TIMP-2 mRNA expression. Nephrol Dial Transplant 1997;12:443-448.
8. Ishikawa Y, Kitamura M: Inhibition of glomerular cell apoptosis by heparin. Kidney Int 1999;56:954-963.
9. Gambaro G, Cavazzana AO, Luzi P, et al: Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 1992;42:285-291.
10. Benchetrit S, Mandelbaum A, Bernheim J, et al: Altered vascular reactivity following partial nephrectomy in the rat: a possible mechanism of the blood-pressure-lowering effect of heparin. Nephrol Dial Transplant 1999;14:64-69.
11. Hansen PM, Jensen T, Kofoed-Enevoldsen A, et al: Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 1995;345:421-422.
12. Van der Pijl JW, van der Woude FJ, Geelhoed-Duijvestijn PH, et al: Danaparoid sodium lowers proteinuria in diabetic nephropathy. J Am Soc Nephrol 1997;8:456-462.
13. Yanagita M, Ishii K, Ozaki H, et al: Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol 1999;10:2503-2509.
14. Yanagita M, Arai H, Ishii K, Nakano T, et al: Gas 6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol 2001;158:1423-1432.
15. Nagai K, Arai H, Yanagita M, et al: Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003;278:18229-18234.
16. Walker RG, Yu SH, Oewn JE, et al: The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial. Clin Nephrol 1990;34:103-107.
17. Woo KT, Lee GSL, Lau YK, et al: Effects of triple therapy in IgA nephritis: a follow-up study 5 years later. Clin Nephrol 1991;36:60-66.
18. Lee GSL, Choong HL, Chiang GSC, et al: Three-year randomized controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephropathy and renal impairment. Nephrol 1997;3:117-121.